Zonisamide Capsule
Product Images NDC 69097-861

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 69097-861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zonisamide 100mg

Each capsule contains 100mg of zonisamide USP, a medication used to treat seizures. It is recommended to store capsules in a dry place protected from light at a temperature of 20° to 25°C (68° to 77°F). The medication is manufactured by Invagen Pharmaceuticals, Inc., a subsidiary of Cipla Ltd., and supplied with a medication guide to be dispensed to each patient. This information is intended for pharmacists.*

FDA Label Image

Figure 01

FDA Label Image

Figure 02

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.